Strong Revenue Growth:
Recent disclosures show rising total revenue and accelerating Galleri test volumes year over year, with both full‑year 2025 and early 2026 reporting continued momentum. Quarterly updates point to sustained double‑digit growth across revenue and volumes.
Strategic Partnerships:
Announcements detail deeper channel integrations and access, including Epic EHR ordering, Quest connectivity, and collaborations with health systems, employers, and digital‑health platforms. International arrangements, such as a Samsung collaboration and a Canada launch, further extend reach.
Investor Backing & Capital Strength:
The company secured additional financing in late 2025 and reports a cash position described as providing a multi‑year runway. Public company status post‑spin‑off offers direct access to capital markets to fund commercialization and regulatory efforts.
